Drug safety study for children already on certain medicines
Part of Blood & lymphatic, Brain & nervous system, Genetic & congenital, Heart & circulation, Hormones & metabolism, Infections, Lungs & breathing, Mental health, Pain, Skin, Women’s health & pregnancy clinical trials.
This study measures how certain medicines move through the body and checks their safety in children. It may help doctors better understand dosing and side effects in kids who are already receiving these treatments, or in some kids who recently tested positive for COVID-19.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be under 21 years old.
- A parent/guardian (or you, if you’re the adult participant) must be able to understand the consent process and agree to paperwork.
- You are either already receiving the specific study medicines now, or you are NOT on them but you tested positive for COVID-19 within the last 60 days.
- You cannot be known to be pregnant.
- You must not have had certain major treatments/procedures or devices recently (like recent dialysis, recent transplants, therapeutic cooling, plasmapheresis, or a heart pump).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at heart disease risk in children and young adults (ages 6-25) with long-term health conditions like certain heart, kidney, or diabetes disorders. The goal is to better understand and manage heart risks early.
This study looks at how a kidney-related blood-pressure system works in children and teenagers, comparing those with newly diagnosed primary (no known cause) high blood pressure to those with normal blood pressure. It may help doctors better understand childhood blood-pressure changes and guide future care.
This trial looks at how well different numbing and pain-relief medicines work in children during routine care. It may help doctors choose safer, better pain control for kids who need these medicines.
This trial studies whether PF-07321332 (with ritonavir) helps children under 18 who have COVID-19 at home but are at high risk of severe illness. It looks at whether starting treatment early can reduce progression to worse disease.
This study measures how common medicines move through a breastfeeding parent’s milk and checks safety in both the parent and breastfed baby. It may help doctors use these medicines more safely while you continue breastfeeding.
This study measures how children’s bodies handle medicines they are already prescribed as standard care. It may help doctors choose safer, more accurate doses for children in the future.
Hear when a new Pulmonary Arterial Hypertension trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.